CARL — Carlsmed, Inc. Common Stock
NASDAQ · Healthcare · Health Information Services
$16.90
+$0.53 (+3.24%)
Carlsmed, Inc. Common Stock (CARL) is a health information services company listed on NASDAQ. It is led by Michael John Cordonnier, based in 1800 Aston Avenue, Carlsbad, CA, United States, 92008, with about 127 employees. Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Net income was -$8.5M. CARL currently screens at market cap $299.7M.
Use this CARL page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CARL quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CARL SEC filings page. Lician reads the product cache first so this HTML stays unique to Carlsmed, Inc. Common Stock even when a live quote feed is slow.
About Carlsmed, Inc. Common Stock
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
CARL Key Statistics
Market Cap
$299.71M
Volume
18,164
Previous Close
$15.80
Day Range
$15.51 – $15.89
P/B Ratio
3.25
EPS
-$0.40
Revenue
$0.00
Net Income
-$8.53M
Gross Profit
$0.00
Free Cash Flow
$0.00
Employees
127
CARL Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2025 | FY2025 | FY2025 | FY2024 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$8.53M | -$6.77M | -$5.73M | -$7.81M | -$6.28M |
| EPS (Diluted) | -$0.40 | -$1.47 | $0.00 | -$2.06 | -$1.55 |
Total Assets
$134.86M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$115.37M
Operating Cash Flow
-$23.66M
Free Cash Flow
$0.00
Carlsmed, Inc. Common Stock Company Information
- Co-Founder, Chairman, CEO & President
- Michael John Cordonnier
- Headquarters
- 1800 Aston Avenue, Carlsbad, CA, United States, 92008
- Website
- carlsmed.com
- Phone
- 760 766 1923
- IPO / Founded
- 2025-07-23
- Sector
- Healthcare
- Industry
- Health Information Services